miRagen Reports Third Quarter 2019 Results and Provides Corporate Update

Ads

You May Also Like

TiGenix: Transparency notifications pursuant to Article 14 of the Law of May 2, 2007

REGULATED INFORMATIONPRESS RELEASE Transparency notifications pursuant to Article 14 of the Law of May ...

G1 Therapeutics Announces Proposed Offering of Common Stock

RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: ...

Kura Oncology Announces Pricing of $67 Million Public Offering of Common Stock

SAN DIEGO, June 28, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage ...